Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
11.76
+0.36 (3.16%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees as of December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
$881,344
Profits / Employee
-$231,211
Market Cap
3.49B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Envista Holdings | 12,800 |
Perrigo Company | 9,140 |
PTC Therapeutics | 1,055 |
Axonics | 797 |
Apellis Pharmaceuticals | 706 |
PROCEPT BioRobotics | 626 |
Prestige Consumer Healthcare | 570 |
TG Therapeutics | 264 |
FOLD News
- 3 days ago - American Citizens Abroad (ACA) joins amicus brief supporting voting by U.S. citizens overseas - GlobeNewsWire
- 3 days ago - 3 Attractive Biotechs With Recent Positives - Seeking Alpha
- 6 days ago - Amicus: Teva Settlement Clears Revenue Path Forward For Galafold - Seeking Alpha
- 7 days ago - Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug - Benzinga
- 7 days ago - Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva - GlobeNewsWire
- 20 days ago - Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024 - GlobeNewsWire
- 25 days ago - 'Boring' Amicus Therapeutics Is Making Progress - Seeking Alpha
- 4 weeks ago - 3 'Repeatable' Biotech Trades - Seeking Alpha